From: Identifying an early treatment window for predicting breast cancer response to neoadjuvant chemotherapy using immunohistopathology and hemoglobin parameters
NS
MC
HER2
ER
TN
tHb
%tHb cycle 1
%tHb cycle 2
%tHb cycle 3
rho
0.42
0.45
0.29
0.12
0.48
0.50
0.52
0.69
P
P = 0.001
P < 0.001
P = 0.035
P = 0.364